News A Novel Therapeutic Strategy for Ovarian Cancer Subtype With Poor Prognosis More than 50% of patients with ovarian clear cell carcinomas display mutations in the ARID1A gene. Scientists have found that loss of ARID1A function enhances a cellular stre
Technology Networks,
Mutations in the ARID1A gene are present in more than 50% of ovarian clear cell carcinomas (OCCC), for which effective…